Drug Interactions between naproxen and Tegretol
This report displays the potential drug interactions for the following 2 drugs:
- naproxen
- Tegretol (carbamazepine)
Interactions between your drugs
No interactions were found between naproxen and Tegretol. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
naproxen
A total of 385 drugs are known to interact with naproxen.
- Naproxen is in the drug class Nonsteroidal anti-inflammatory drugs.
-
Naproxen is used to treat the following conditions:
- Ankylosing Spondylitis
- Aseptic Necrosis
- Back Pain
- Bursitis
- Chronic Myofascial Pain
- Costochondritis
- Diffuse Idiopathic Skeletal Hyperostosis
- Dysautonomia
- Fever
- Frozen Shoulder
- Gout, Acute
- Headache
- Herniated Disk
- Juvenile Rheumatoid Arthritis
- Muscle Pain
- Neck Pain
- Osteoarthritis
- Pain
- Period Pain
- Radiculopathy
- Rheumatoid Arthritis
- Sciatica
- Spondylolisthesis
- Tendonitis
- Transverse Myelitis
Tegretol
A total of 681 drugs are known to interact with Tegretol.
- Tegretol is in the drug class dibenzazepine anticonvulsants.
- Tegretol is used to treat the following conditions:
Drug and food interactions
carBAMazepine food
Applies to: Tegretol (carbamazepine)
You should preferably avoid the regular consumption of grapefruits and grapefruit juice while taking carBAMazepine. This can cause carBAMazepine levels to increase. You should report signs of carBAMazepine side effects such as nausea, visual disturbances, dizziness, or muscle weakness to your doctor. You should avoid or limit the use of alcohol while being treated with carBAMazepine. Alcohol can increase the nervous system side effects of carBAMazepine such as dizziness, drowsiness, and difficulty concentrating. Some people may also experience impairment in thinking and judgment. Talk to your doctor or pharmacist if you have any questions or concerns.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See Also
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.